Xbiotech Inc (XBIT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -45,540 | -38,531 | -24,557 | -32,900 | -17,414 |
| Depreciation Amortization | 1,686 | 1,745 | 1,744 | 2,614 | 2,648 |
| Income taxes - deferred | 5 | N/A | N/A | N/A | N/A |
| Accounts receivable | N/A | N/A | N/A | N/A | 4,113 |
| Accounts payable and accrued liabilities | -688 | -364 | 91 | 357 | -514 |
| Other Working Capital | 3,640 | -1,459 | 2,719 | 7,600 | 4,685 |
| Other Operating Activity | 977 | 7,646 | 1,278 | 7,505 | 75,927 |
| Operating Cash Flow | $-39,920 | $-30,963 | $-18,725 | $-14,824 | $69,445 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | 61,859 | -63,307 | N/A |
| PPE Investments | -289 | -1,304 | -362 | -585 | -3,525 |
| Investing Cash Flow | $-289 | $-1,304 | $61,497 | $-63,892 | $-3,525 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -10,250 | 10,250 | N/A | N/A | N/A |
| Common Stock Issued | N/A | 200 | 5 | N/A | 7,995 |
| Dividend Paid | N/A | N/A | N/A | N/A | -75,003 |
| Other Financing Activity | 0 | 0 | -14 | 0 | 0 |
| Financing Cash Flow | $-10,250 | $10,450 | $-9 | $N/A | $-67,008 |
| Exchange Rate Effect | 3,333 | -5,529 | -46 | -961 | 705 |
| Beginning Cash Position | 172,677 | 200,023 | 157,306 | 236,983 | 237,366 |
| End Cash Position | 125,551 | 172,677 | 200,023 | 157,306 | 236,983 |
| Net Cash Flow | $-47,126 | $-27,346 | $42,717 | $-79,677 | $-383 |
| Free Cash Flow | |||||
| Operating Cash Flow | -39,920 | -30,963 | -18,725 | -14,824 | 69,445 |
| Capital Expenditure | -289 | -1,304 | -362 | -585 | -3,525 |
| Free Cash Flow | -40,209 | -32,267 | -19,087 | -15,409 | 65,920 |